PHILADELPHIA (WPVI) -- Philadelphia has the highest diabetes rate of America's 10 biggest cities, with a rate that's doubled since 2002, according to the Department of Public Health. Over 15% of ...

A free 6-month program run by Blue Circle Health helps fill in care gaps for adults with type 1 diabetes (T1D), whether they are managed by an endocrinologist or primary care, and has recently been ...

Nearly half of Americans 65 and older have prediabetes, and Montrose Regional Health is offering a program to help prevent ...

CLEVELAND, Ohio — For people with Type 1 diabetes, life is penny-pinching to afford life-saving insulin, scrambling to book medical appointments and fighting to get health insurance to pay up. Blue ...

True to its namesake geometric figure, Fractyl Health’s Type 2 diabetes treatment program now comprises multiple components that all share overarching characteristics—namely, a goal of reversing ...

HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead ...

Elizabeth Bolt used to drink three 32 oz. Mountain Dews a day. For breakfast, she’d have a Coke. For lunch, she’d have a candy bar. When she used to work at Hardee’s, she drank a dozen Mountain Dews a ...

CareFirst BlueCross BlueShield is joining forces with Ryse Health, a company that specializes in providing in-person and virtual care for patients with uncontrolled Type 2 diabetes, in hopes of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ORLANDO — A pilot ...

In Arizona, 1 in 3 people are living with diabetes or prediabetes, both of which occur when the body can’t use insulin properly and result in high blood sugar. The issue is even more challenging right ...

In a recent cohort study published in JAMA Network Open, researchers from China investigated the effect of a multidisciplinary diabetes management program on the risk of dementia in patients with type ...

- VX-264 Phase 1/2 enrollment and dosing complete in Parts A and B: VX-264 was generally safe and well tolerated; efficacy data are not supportive of further clinical advancement - - Zimislecel ...